Literature DB >> 22460014

The effectiveness and safety of vertebroplasty for osteoporotic vertebral compression fractures. A double blind, prospective, randomized, controlled study.

Umile Giuseppe Longo1, Mattia Loppini, Luca Denaro, Maria Luisa Brandi, Nicola Maffulli, Vincenzo Denaro.   

Abstract

BACKGROUND: Vertebral compression fractures (VCFs) constitute a major health care problem in western countries. Several treatments modalities are available to relieve pain and allow increased activities. Percutaneous vertebroplasty (the injection of bone cement into the fractured vertebral body) is a relatively new procedure to manage patients with these fractures. The aim of this study is to evaluate the efficacy and safety of percutaneous vertebroplasty compared with standard conservative care. METHODS/DESIGNS: In this double blind, prospective, randomized, controlled study the short- (3 months), medium- (6 months) and long-term (24 months) efficacy and safety of vertebroplasty to alleviate pain and improve function for painful osteoporotic vertebral fractures will be compared to standard conservative therapy. Conservative care will consist of 3 weeks of bed rest, wearing a rigid hyperextension corset, followed by 2-3 months in a Cheneau brace. In each of the two groups, patients will also receive treatment for osteoporosis according to their metabolic profile. Two hundred patients with painful osteoporotic vertebral compression fractures will be recruited over a 3 year period according to inclusion and exclusion criteria. We will randomly assign participants to receive either vertebroplasty or conservative care. Subjects will complete a battery of validated, standardized measures of pain, functional disability, and health related quality of life questionnaires at baseline and at post-randomization time points (1, 3, 6, 12 and 24 months). Each patient will be evaluated for pre-operative MRI, and pre- and post-operative radiographs; all scans will be evaluated independently by 2 orthopaedic surgeons. Laboratory tests to assess their metabolic bone profile will be also performed. Our primary outcome will be change from baseline to 1, 3, 6, 12 and 24 months in the VAS score between the 2 groups. DISCUSSION: To date, vertebroplasty has been not been compared with standard conservative care for the management of patients with painful osteoporotic vertebral fractures in a randomised controlled trial. Therefore, the results of this study will allow to draw firm conclusions on this controversial topic.

Entities:  

Year:  2010        PMID: 22460014      PMCID: PMC3004456     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  31 in total

1.  Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) Instrument and comparison with the SF-36.

Authors:  Richard H Osborne; Graeme Hawthorne; Elizabeth A Lew; Len C Gray
Journal:  J Clin Epidemiol       Date:  2003-02       Impact factor: 6.437

2.  Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes?

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

Review 3.  MR imaging of the shoulder after surgery.

Authors:  Marco Zanetti; Juerg Hodler
Journal:  Radiol Clin North Am       Date:  2006-07       Impact factor: 2.303

Review 4.  Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review.

Authors:  Wendy T Ploeg; Albert G Veldhuizen; Bertram The; Maurits S Sietsma
Journal:  Eur Spine J       Date:  2006-07-06       Impact factor: 3.134

5.  A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain.

Authors:  M Roland; R Morris
Journal:  Spine (Phila Pa 1976)       Date:  1983-03       Impact factor: 3.468

6.  Vertebroplasty and kyphoplasty.

Authors:  Vincenzo Denaro; Umile Giuseppe Longo; Nicola Maffulli; Luca Denaro
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

7.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

Review 8.  Minimally invasive treatments of osteoporotic vertebral compression fractures.

Authors:  Frank M Phillips
Journal:  Spine (Phila Pa 1976)       Date:  2003-08-01       Impact factor: 3.468

Review 9.  Vertebral augmentation in osteoporosis and bone metastasis.

Authors:  Krzysztof Siemionow; Isador H Lieberman
Journal:  Curr Opin Support Palliat Care       Date:  2007-12       Impact factor: 2.302

10.  A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.

Authors:  Rachelle Buchbinder; Richard H Osborne; Peter R Ebeling; John D Wark; Peter Mitchell; Chris Wriedt; Stephen Graves; Margaret P Staples; Bridie Murphy
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

View more
  15 in total

1.  Reply to comment on Andrei et al.: The variability of vertebral body volume and pain associated with osteoporotic vertebral fractures: conservative treatment versus percutaneous transpedicular vertebroplasty.

Authors:  Iulian Popa
Journal:  Int Orthop       Date:  2018-02-07       Impact factor: 3.075

2.  Combination therapy with percutaneous osteoplasty and transcatheter arterial chemoembolization for the treatment of pelvic bone metastases: preliminary report.

Authors:  Lu Zhang; Benyun Wang; Pijian Cao; Qinglin Zhang; Xunwei Liu; Min Li
Journal:  Support Care Cancer       Date:  2020-09-18       Impact factor: 3.603

3.  Biomechanical comparison of vertebral augmentation with silicone and PMMA cement and two filling grades.

Authors:  Tobias L Schulte; Alexander Keiler; Felix Riechelmann; Tobias Lange; Werner Schmoelz
Journal:  Eur Spine J       Date:  2013-07-24       Impact factor: 3.134

4.  Risk factor analysis of pulmonary cement embolism during percutaneous vertebroplasty or kyphoplasty for osteoporotic vertebral compression fractures.

Authors:  Dexin Zou; Shengjie Dong; Wei Du; Bing Sun; Xifa Wu
Journal:  J Orthop Surg Res       Date:  2021-05-13       Impact factor: 2.359

5.  Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.

Authors:  Rachelle Buchbinder; Renea V Johnston; Kobi J Rischin; Joanne Homik; C Allyson Jones; Kamran Golmohammadi; David F Kallmes
Journal:  Cochrane Database Syst Rev       Date:  2018-11-06

6.  Radiological and clinical outcomes of balloon kyphoplasty for osteoporotic vertebral compression fracture in patients with rheumatoid arthritis.

Authors:  Ji Guo; Weifeng Zhai; Licheng Wei; Jianpo Zhang; Lang Jin; Hao Yan; Zheng Huang; Yongwei Jia
Journal:  J Orthop Surg Res       Date:  2021-07-06       Impact factor: 2.359

7.  Significance of preoperative MRI in establishing levels of augmentation for percutaneous vertebroplasty.

Authors:  Paul J Graziotti; Cherie R Graziotti; Adele M Sangster
Journal:  J Pain Res       Date:  2013-05-10       Impact factor: 3.133

Review 8.  Tissue engineering for rotator cuff repair: an evidence-based systematic review.

Authors:  Nicola Maffulli; Umile Giuseppe Longo; Mattia Loppini; Alessandra Berton; Filippo Spiezia; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-10       Impact factor: 5.443

Review 9.  Growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration.

Authors:  Umile Giuseppe Longo; Stefano Petrillo; Edoardo Franceschetti; Nicola Maffulli; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-03       Impact factor: 5.443

Review 10.  Tissue engineered strategies for skeletal muscle injury.

Authors:  Umile Giuseppe Longo; Mattia Loppini; Alessandra Berton; Filippo Spiezia; Nicola Maffulli; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-10       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.